Research

Hormonal

Adding Subetta® (affinity-purified antibodies against the insulin receptor beta-subunit) and cholecalciferol (Vitamin D) to standard therapy significantly improves glycemic control, lipid profiles, and reduces body mass index in elderly women with type 2 diabetes compared to standard therapy alone.

For elderly women with Type 2 Diabetes who are struggling with weight gain and high blood sugar despite standard medication, adding Vitamin D (4000 IU daily after a loading phase) and Subetta® to their existing regimen (Metformin/Gliclazide) can significantly improve blood sugar, cholesterol, and weight loss without causing dangerous low blood sugar episodes.

ModerateSupportsMEDIUM confidence
The addition of Subetta® and cholecalciferol to the treatment of patients with type 2 diabetes contributed to the achievement of target indicators of carbohydrate metabolism, improved lipid profile, and weight loss.
С. В. Булгакова et al. · Meditsinskiy sovet = Medical Council · 2023

Why this rating

Small sample size (n=80), short duration (6 months), and lack of long-term follow-up or broader demographic representation.

Source

A safe approach to the treatment of type 2 diabetes in elderly patients

С. В. Булгакова et al. · Meditsinskiy sovet = Medical Council · 2023

DOI 10.21518/ms2023-151

rct · n=80
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →